|
Volumn 26, Issue 2 SUUPL., 1999, Pages 55-62
|
MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DNA TOPOISOMERASE INHIBITOR;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
IRINOTECAN;
LY 329201;
METHOTREXATE;
PACLITAXEL;
PEMETREXED;
PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
COLON CARCINOMA;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG POTENTIATION;
HUMAN;
HUMAN CELL;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
RADIATION DOSE;
TUMOR XENOGRAFT;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
ENZYME INHIBITORS;
FOLIC ACID ANTAGONISTS;
GLUTAMATES;
GUANINE;
LUNG NEOPLASMS;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED BALB C;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
THYMIDYLATE SYNTHASE;
TUMOR CELLS, CULTURED;
|
EID: 0032964203
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (45)
|
References (37)
|